Polymorphism in gene coding for ACE determines different development of myocardial fibrosis in rats

Biochemistry, Genetics and Molecular Biology

• Angiotensin-Converting Enzyme 100%
• Enzyme Activity 35%
• BioBreeding Rat 28%
• Angiotensin Blood Level 28%
• Isoprenaline 28%
• Gene Polymorphism 21%
• Plasma Renin Activity 7%
• Microsatellite Marker 7%
• Cell Proliferation 7%
• Body Weight 7%
• Protein Content 7%
• Brown Norway Rat 7%
• Rat Strain 7%
• Enzyme Polymorphism 7%
• Metalloproteinase 7%
• Metalloendopeptidase 7%
• Gelatinase B 7%
• MMP9 7%
• Gelatinase A 7%
• MMP2 7%
• Messenger RNA 7%
• Polymerase Chain Reaction 7%
• Fibronectin 7%
• Blood Plasma 7%

Neuroscience

• Dipeptidyl Carboxypeptidase 100%
• Cardiac Fibrosis 100%
• Blood Plasma 26%
• Isoprenaline 21%
• DNA Polymorphism 15%
• MMP9 5%
• Metalloendopeptidase 5%
• MMP2 5%
• Fibronectin 5%
• Cell Proliferation 5%
• Enzyme Polymorphism 5%
• Left Ventricular Hypertrophy 5%
• Plasma Renin Activity 5%
• Receptor 5%
• Messenger RNA 5%
• Polymerase Chain Reaction 5%
• Microsatellite 5%

Pharmacology, Toxicology and Pharmaceutical Science

• Heart Muscle Fibrosis 100%
• Dipeptidyl Carboxypeptidase 100%
• BioBreeding Rat 21%
• Isoprenaline 21%
• Brown Norway Rat 5%
• Rat Strain 5%
• Receptor 5%
• Fibronectin 5%
• Heart Left Ventricle Hypertrophy 5%
• Gelatinase A 5%
• Gelatinase B 5%
• Fibrosis 5%
• Renin 5%
• Metalloproteinase 5%
• Messenger RNA 5%
• Cardiovascular Disease 5%